immune complexes (6) , leading ultimately to diabetic tissue damage.
In this report, we have tested this hypothesis, using nonenzymatically glycosylated collagen. Binding of both albumin and IgG averaged four times the amount bound to unmodified collagen. Both albumin and IgG bound to nonenzymatically glycosylated collagen retained their ability to form immune complexes in situ with free antibody and antigen, respectively.
Materials and Methods
Collagen hnmobilization. Soluble collagen from calfskin (Elastin Products, Elastin Company, Pacific, MO) was immobilized on agarose by a previously described technique (17) , using Affi-Gel 10 (Bio-Rad Laboratories, Richmond, CA), rather than CNBr-activated resin. The amount of collagen bound to the resin (determined by quantitating total amino acids after acid hydrolysis of an aliquot) was 17.2 mg/ml of gel (18) .
Nonenzwnatic Glycosylation of Immobilized Collagen. Immobilized collagen (86 mg) was
washed with 50 ml of 0.5 M phosphate buffer, pH 7.5, and then resuspended in 5 ml of buffer to which ~glucose was added to a final concentration of 500 mM. The immobilized collagen samples were incubated with glucose at 37°C. After 10 d, the gels were washed with 200 ml of PBS and the samples were then stored at 4°C. Unmodified immobilized collagen was prepared by incubating and washing as described without added glucose. All solutions contained 3 mM NAN3.
Radioiodination of Proteins.
Bovine serum albumin (BSA; Sigma Chemical Company, St. Louis, MO) and rabbit anti-BSA IgG (Miles Laboratories, Elkhart, IN) purified on diethylaminoethyl (DEAE)-Affi-Gel Blue (Bio-Rad Laboratories) were iodinated with ~25I-NaI using the IODOGEN procedure (19) . Specific activities of BSA and IgG were 507,000 cpm/nmol and 492,000 cpm/nmol, respectively. Samples were counted in a Packard Tricarb Scintillation Counter (Model 3002; Packard Instrument Co. Inc., United Technologies, Downers Grove, IL) and protein was determined by the Bradford method (20) . The amount of ligand bound to immobilized collagen was determined by filtering aliquots corresponding to 1 mg of collagen on Durapore hydrophilic membranes (Millipore, Bedford, MA). Filters were washed six times with 0.5 ml of 0.2 M glycine buffer, pH 8.0, followed by six washes of the same buffer containing 2 M NaCI. Samples containing ~4C were hydrolyzed with 6 N HCI at 110°C for 12 h and then neutralized before addition of hydrofluor scintillation fluid. Samples containing ~I were counted directly.
Binding of Lysine and
Binding of lysine and proteins to agarose alone was assessed under similar conditions. No binding of [14C]lysine was detected, and binding of ~I proteins gave blank values of 2-9 pmol/aliquot.
In Situ Formation oflmmune Complexes.
Binding of unlabeled proteins to nonenzymatically glycosylated collagen was accomplished by incubating immobilized collagen (8.6 mg) with BSA or IgG (25 nmol/mg collagen) as described above. After filtering and washing, 0.5 ml of PBS containing 500 #g of 12~I-BSA or ~2~I-IgG was added to the filter and incubated at room temperature for 10 min. This procedure was repeated four times and the samples were then washed six times with 1 ml of buffer. The amount of radioactive antigen or antibody fixed to the corresponding planted antibody or antigen bound to immobilized collagen was determined by counting material retained on the filter.
Data Analysis. Statistical significance of differences observed between paired samples were evaluated using Student's t-test.
Results

Binding of Lysine and Proteins to Nonenzymatically Glycosylated Collagen.
Incubation of [14C]lysine with nonenzymatically glycosylated collagen immobilized on agarose 5 M resulted in a nearly fivefold increase in the amount of amino acid bound over that observed after incubation with unmodified collagen (Table I) . The number of nanomoles of radiolabeled amino acid bound to reactive glycosylated lysine residues in these experiments corresponds to 1.86% of the total collagen lysine residues present. This is equivalent to one glucose-derived amino group binding site for each 200-rim length of individual tropocollagen molecules which, when linked end-to-end and side-to-side, make up the collagen fibril (21) . The increase in binding of l~SI-serum albumin to nonenzymatically glycosylated collagen was very similar in degree to that observed with iysine. Incubation of 125I-IgG with nonenzymatically glycosylated collagen resulted in a nearly identical number of picomoles being bound. The number of glucose-derived reactive binding sites cannot be extrapolated from this data, however, since an unknown number of lysine residues within the protein may not be accessible. Several lysine residues within a single protein molecule may simultaneously bind at separate reactive sites, and steric hinderance by bound protein molecules may act to prevent further protein binding.
In Situ Formation ofhnmune Complexes. The ability of antigen (BSA) or antibody (IgG) bound by nonenzymatically glycosylated collagen to form immune complexes in situ was established by incubating each with 125I-BSA and with 1~sI--IgG (Table II) . Nonspecific binding of free ligand (antigen or antibody) was evaluated by incubating each with its glycosylated-collagen-bound form. Low levels of nonspecific binding were observed in both cases. In contrast, the amount of ~SI-antigen (BSA) or t25I-antibody (IgG) fixed to the corresponding planted antibody or antigen bound to glycosylated collagen was strikingly similar to that observed in the simple binding experiments described above. 4.4 ± 13,1 pmol 216.5 + 29.1 pmol * Binding of unlabeled proteins to nonenzymatically glycosylated collagen was accomplished by incubating immobilized calfskin collagen (8.6 rag) with 2.5 mg protein as described in Table 1 . * Amount of t~I-antigen (BSA) or t*Sl-antibody (IgG) fixed to the corresponding planted antibody or antigen bound to glycosylated collagen (mean 4-SEM), n = 4. Discussion The reuslts reported in this communication demonstrate that amino acids and proteins are bound specifically by nonenzymatically glycosylated, long-lived structural proteins such as collagen. Proteins bound in this manner to nonenzymatically glycosylated collagen are able to function as planted antigens or planted antibodies in the subsequent in situ formation of immune complexes.
It should be noted that the collagen utilized in these experiments, though obtained from skin of young animals, undoubtedly had undergone some degree of nonenzymatic glycosylation in vivo before isolation. These nonenzymatic glycosylation products could form subsequently the brown pigments that crosslink proteins, and could account for the low levels of binding consistently observed with "unmodified" collagen. The nonphysiological glucose concentration used in these experiments was selected to accelerate the rate of reactive-site formation. In vivo, this process would occur over a much longer period of time, consistent with the slow evolution of clinically demonstrable diabetic vascular disease. The concentrations of serum protein used in these experiments were considerably less than those in plasma, however, a factor that would tend to reduce the amount of protein bound.
Previously published immunopathological studies of diabetic rnicrovascular disease in the kidney have demonstrated IgG in a linear pattern resembling that seen in anti-basement membrane nephropathy (4, 5) . However, the failure to show fixation of IgG from eluates of diabetic kidneys to normal extracellular basement membranes in vitro was interpreted as evidence against the participation of this type of immunological mechanism in the pathogenesis of diabetic microvascular disease. More recently, discontinuous granular ("lumpy-bumpy") deposits of immunoglobulins identified by electron microscopy as immune complexes have been reported in diabetic kidneys (22) , and activated-complement, (poly C9) membrane-attack complex deposition has also been described (9) . Both patterns of imrnunoglobulin deposition are consistent with current concepts of in situ immune complex formation (6) .
Both the binding of plasma protein constituents to nonenzymaticaUy glycosylated perivascular structural proteins and their subsequent participation in the in situ formation of immune complexes may be favored in vivo by several pathophysiologic and biochemical features of the diabetic state. The well-described increase in vascular permeability associated with diabetes would result in a higher concentration of extravasated plasma proteins available for binding either primarily, as planted antigen or antibody, or secondarily, in immune complex formation. Removal of proteins or immune complexes bound to nonenzymatically glycosylated matrix may be reduced due to diabetes-associated defects in mesangial clearance mechanisms (23) and perhaps also because of a decreased susceptibility to proteolytic degradation associated with nonenzymatic protein glycosylation (24) .
The data presented in this report suggest that the chronic tissue damage associated with long-term diabetes meilitus may arise in part from continuous accumulation of serum proteins and in situ immune complex formation by accumulated immunoglobulins and/or antigens bound to long-lived structural proteins that have undergone excessive nonenzymatic glycosylation. The essen-tial chemical irreversibility of late nonenzymatic glycosylation products once formed, together with the extremely long survival times of many structural tissue proteins, suggest that therapeutic attempts to normalize blood glucose in diabetic patients late in the course of the disease may have little effect on the progression of these diabetic complications once they have become clinically manifest.
Summary
The chronic tissue damage associated with long-term diabetes mellitus may arise in part from in situ immune complex formation by accumulated immunoglobulins and/or antigens bound to long-lived structural proteins that have undergone excessive nonenzymatic glycosylation. In this report, we have tested this hypothesis using nonenzymatically glycosylated collagen. Binding of both albumin and IgG averaged four times the amount bound to unmodified collagen. Both albumin and IgG (anti-BSA) bound to nonenzymatically glycosylated collagen retained their ability to form immune complexes in situ with free antibody and antigen.
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